160 related articles for article (PubMed ID: 10572744)
21. [Effect of mexidol on clinical and biochemical parameters of perinatal hypoxia in newborn children].
Levitina EV
Eksp Klin Farmakol; 2001; 64(5):34-6. PubMed ID: 11764497
[TBL] [Abstract][Full Text] [Related]
22. [Morphological changes in brain tissues of rat with local permanent ischemia model under the action of 2-methyl-6-ethyl-3-hydroxypyridine hemisuccinate].
Bagdasarian NA; Khostikian NG; Alikhanian KB; Meliksetian VS; Bagdasarian MG; Stepanian AG; Kukhtarova AM; Mirzoian NR
Eksp Klin Farmakol; 2014; 77(12):10-3. PubMed ID: 25739186
[TBL] [Abstract][Full Text] [Related]
23. [Metabolic effects of mexidol in complex treatment of chronic brain ischemia].
Demchenko EIu; Kulakova NV; Semiglazova TA; Golovacheva AB; Borodulina EV; Udut VV
Eksp Klin Farmakol; 2008; 71(6):13-5. PubMed ID: 19140508
[TBL] [Abstract][Full Text] [Related]
24. [Effect of komplamin and nikoshpan on brain circulation and metabolism in the postischemic period].
Nagornaia GV; Gaevyĭ MD
Farmakol Toksikol; 1988; 51(1):38-41. PubMed ID: 3360105
[TBL] [Abstract][Full Text] [Related]
25. [Experimental and clinical research on the effect of senzit on the cerebral blood flow and hemostatic function in cerebral ischemia].
Burtsev EM; Miller LG; Gushchin AS; Shprakh VV; Savkov VS
Farmakol Toksikol; 1986; 49(5):97-101. PubMed ID: 3770185
[TBL] [Abstract][Full Text] [Related]
26. Effects of hydroxypyridine derivatives mexidol and emoxypin on the reparative processes in rabbit eye on the models of corneal epithelial defect and conjunctival ischemia.
Chesnokova NB; Beznos OV; Pavlenko TA; Zabozlaev AA; Pavlova MV
Bull Exp Biol Med; 2015 Jan; 158(3):346-8. PubMed ID: 25573366
[TBL] [Abstract][Full Text] [Related]
27. [The effect of 3-oxypyridine and succinic acid derivatives on the resistance to acute cerebral ischemia].
Volchegorskiĭ IA; Miroshnichenko II; Rassokhina LM; Faĭzullin RM; Priakhina KE; Malkin MP; Kalugina AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(12):123-127. PubMed ID: 25726791
[TBL] [Abstract][Full Text] [Related]
28. [Effect of euphylline and no-shpa on cerebrovascular resistance and the survivability of animals after cerebral ischemia].
Gaevyĭ MD; Ali AV
Farmakol Toksikol; 1987; 50(2):89-91. PubMed ID: 3582642
[TBL] [Abstract][Full Text] [Related]
29. [The role of dopamine in regulating the cerebral circulation in extreme conditions].
Pchelintseva TR; Pogorelyĭ VE; Gaevyĭ MD
Fiziol Zh SSSR Im I M Sechenova; 1989 Nov; 75(11):1596-601. PubMed ID: 2628017
[TBL] [Abstract][Full Text] [Related]
30. [The effect of cytochrome c preparations on the autoregulation of the cerebral blood flow in ischemia].
Pogorelyĭ VE; Gaevyĭ MD; Arl't AV; Davidov ER; Gatsura VV
Eksp Klin Farmakol; 1996; 59(5):18-20. PubMed ID: 9026201
[TBL] [Abstract][Full Text] [Related]
31. [The study of the efficacy and safety of Mexidol and Mexidol Forte 250 in patients with chronic cerebral ischemia].
Kutashov VA; Ulyanova OV
Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(12. Vyp. 2):89-92. PubMed ID: 32207723
[TBL] [Abstract][Full Text] [Related]
32. [Dopamine enhancement of the cerebral microcirculation in a local ischemic lesion].
Topchian AV; Balasanian MG; Gan'shina TS; Mirzoian RS
Eksp Klin Farmakol; 1999; 62(6):29-31. PubMed ID: 10650523
[TBL] [Abstract][Full Text] [Related]
33. [The antioxidant treatment of cerebral ischemic lesions].
Rumiantseva SA; Fedin AI; Sokhova ON
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(4 Pt 2):28-31. PubMed ID: 23120774
[No Abstract] [Full Text] [Related]
34. [Efficiency of etoxidol in treating cardiovascular disorders caused by experimental cerebral ischemia].
Blinov DS; Sernov LN; Blinova EV; Balashov VP; Gogina ED; Van'kova LV; Skachilova SIa; Lebedev AB; Belova LA
Eksp Klin Farmakol; 2011; 74(7):13-5. PubMed ID: 21894761
[TBL] [Abstract][Full Text] [Related]
35. [Effect of strophanthin and celanide on the dynamics of development of postischemic cerebrovascular phenomena].
Chan KT; Gaevyĭ MD
Biull Eksp Biol Med; 1981 Nov; 92(11):562-4. PubMed ID: 7317634
[TBL] [Abstract][Full Text] [Related]
36. Comparative analysis of the anxiolytic effects of 3-hydroxypyridine and succinic acid derivatives.
Volchegorskii IA; Miroshnichenko IY; Rassokhina LM; Faizullin RM; Malkin MP; Pryakhina KE; Kalugina AV
Bull Exp Biol Med; 2015 Apr; 158(6):756-61. PubMed ID: 25894772
[TBL] [Abstract][Full Text] [Related]
37. [Correction of free-radical oxidation as a pathogenetic approach to the treatment of acute ischemic stroke].
Chugunov AV; Kamchatnov PR; Mikhaĭlova NA
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(10 Suppl 2):65-8. PubMed ID: 20229636
[TBL] [Abstract][Full Text] [Related]
38. [The effect of ethomersol on local cerebral blood flow and edema of the brain tissue in chronic ischemia].
Vaizova OE; Plotnikova TM; Plotnikov MB
Eksp Klin Farmakol; 1994; 57(1):25-7. PubMed ID: 8142857
[TBL] [Abstract][Full Text] [Related]
39. [The effects of mexidol in pain syndromes].
Danilova ED; Grafova VN; Voronina TA; Reshetniak VK
Eksp Klin Farmakol; 1995; 58(3):17-20. PubMed ID: 7663286
[TBL] [Abstract][Full Text] [Related]
40. [Effect of hydroxymethylethylpyridine succinate on the cardiac electrophysiological and hemodynamic parameters during experimental thoracotomy and acute myocardial ischemia].
Kotliarov AA; Smirnov LD
Eksp Klin Farmakol; 2004; 67(3):14-7. PubMed ID: 15341060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
